Gabriela Brasil Silva
Biographic Data
| ID | 8934153 |
|---|---|
| NAME | Gabriela Brasil Silva |
| GIVEN NAMES | Gabriela Brasil |
| FAMILY NAME | Silva |
| SIGNATURE | SILVA G B |
| AFFILIATIONS | Universidade Estadual de Ponta Grossa |
| ORCID | 0009-0000-4060-1060 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Evidence for the efficacy and safety of pre-exposure prophylaxis (PrEP) in all populations
PrEP (pre-exposure prophylaxis) is a medication used to prevent HIV infection, with the combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) being the most commonly used formulation. This review aims to evaluate the efficacy and safety of PrEP across various populations based on recent studies. Studies published in English, Portuguese, or Spanish from 2018 to 2023 that provided data on HIV incidence or adverse events (AEs) a…
No prominent works on this page.
Evidence for the efficacy and safety of pre-exposure prophylaxis (PrEP) in all populations
PrEP (pre-exposure prophylaxis) is a medication used to prevent HIV infection, with the combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) being the most commonly used formulation. This review aims to evaluate the efficacy and safety of PrEP across various populations based on recent studies. Studies published in English, Portuguese, or Spanish from 2018 to 2023 that provided data on HIV incidence or adverse events (AEs) a…
Adverse effect (1 work) · Emtricitabine (1 work) · HIV-related health complications and treatments (1 work) · HIV/AIDS Research and Interventions (1 work) · Pre-exposure prophylaxis (1 work) · Reproductive tract infections research (1 work) · Tenofovir (1 work)